Morgan Stanley Surmodics Inc Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Surmodics Inc stock. As of the latest transaction made, Morgan Stanley holds 853,915 shares of SRDX stock, worth $35.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
853,915
Previous 1,241,793
31.24%
Holding current value
$35.9 Million
Previous $45.1 Million
44.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SRDX
# of Institutions
111Shares Held
12.6MCall Options Held
200Put Options Held
4.7K-
Trigran Investments, Inc.2.36MShares$99.1 Million6.71% of portfolio
-
Black Rock Inc. New York, NY1.05MShares$44.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA865KShares$36.4 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT801KShares$33.7 Million1.92% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN659KShares$27.7 Million0.36% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $589M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...